Mange danske lægemiddelkandidater

August 29, 2012 12:00 AM

På en top-ti-liste over de europæiske biotekselskabers pipelines portefølje af potentielle lægemidler under udvikling - indtager Danmark en tredjeplads med ca. 125 lægemiddelkandidater, kun overgået af Storbritannien og Tyskland.

Det viser den årlige biotekrapport Beyond borders - Global biotechnology report 2012 fra revisions- og konsulentfirmaet Ernst & Young.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.